Clinical trial
Effect of Rosiglitazone in Nondiabetic Patients With the Metabolic Syndrome
NCT00364221 · University of Colorado, Denver, Other · Completed
Key facts
| NCT number | NCT00364221 |
|---|---|
| Title | Effect of Rosiglitazone in Nondiabetic Patients With the Metabolic Syndrome |
| Official title | The Effect of Rosiglitazone on Adipocyte-derived Cytokines in Nondiabetics With the Metabolic Syndrome |
| Lead sponsor | University of Colorado, Denver, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Metabolic Syndrome, Insulin Resistance |
| Intervention type | Drug |
| Interventions | Rosiglitazone |
| Start date | Nov 1, 2004 |
| Primary completion | Jul 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Aug 15, 2006 |
| Last update posted | Nov 22, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: